Longitudinal Study of Oral Precancerous Lesions: Transformation Rate and Predictive Markers for Malignancy
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Oral precancerous lesions (OPLs) require individualized care. Biomarkers like p53, Ki-67, and epidermal growth factor receptor (EGFR) can predict malignant transformation, aiding early oral cancer detection.
Area Of Science
- Oral Medicine
- Oncology
- Biomarker Research
Background
- Oral precancerous lesions (OPLs) are significant risk factors for oral cancer.
- Early detection and management of OPLs are crucial for preventing malignant transformation.
- Understanding OPL transformation rates and malignancy predictors is key for effective intervention.
Purpose Of The Study
- To evaluate the transformation rate of oral precancerous lesions (OPLs).
- To identify predictive signs of malignancy in OPLs.
- To assess the expression of specific biomarkers correlated with dysplasia grade.
Main Methods
- A longitudinal study followed 200 individuals with clinically diagnosed OPLs for 2 years.
- Immunohistochemistry, histopathology, and clinical examinations were employed.
- Biomarker expression levels (p53, Ki-67, CDKN2A, EGFR) were analyzed in relation to dysplasia grade.
Main Results
- Histopathological examination revealed most OPLs presented with mild dysplasia.
- Significant biomarker expression was observed: p53 (60.0%), Ki-67 (40.0%), CDKN2A (30.0%), and epidermal growth factor receptor (EGFR) (25.0%).
- Biomarker expression levels correlated with the grade of dysplasia.
Conclusions
- Individualized care plans and routine surveillance are essential for patients with OPLs.
- EGFR, Ki-67, and p53 show potential as prognostic markers for identifying malignant transformation.
- Further research is needed to validate these findings and develop tailored therapies for high-risk patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...